The Journal of Immunology · 2000 · 1.3K citations · 8 references
Life SciencesCell BiologyImmunologyInflammationInnate ImmunitySignal TransductionCytokine SignalingImmune Cell SignalingInflammatory Cell ResponsesInflammatory Cell SignalingInflammatory SignalingNeutrophil BiologyChemotactic SignalingExtracellular Signal-regulated Kinase PathwayInflammatory ActivationMonocyte Chemoattractant Protein-1Myeloid Cell ActivationPhagocyte ActivationProtein Tyrosine PhosphorylationTrem1 Signaling
TREM‑1 is a myeloid receptor expressed on neutrophils and a subset of monocytes, whose expression rises in response to bacterial LPS. Engagement of TREM‑1 activates neutrophils and monocytes by triggering cytokine release, degranulation, Ca²⁺ mobilization, ERK1/2 and PLC‑γ phosphorylation, and requires the adapter DAP12. TREM‑1 drives neutrophil and monocyte activation and likely plays a key role in inflammatory responses.
Abstract We have identified new activating receptors of the Ig superfamily expressed on human myeloid cells, called TREM (triggering receptor expressed on myeloid cells). TREM-1 is selectively expressed on blood neutrophils and a subset of monocytes and is up-regulated by bacterial LPS. Engagement of TREM-1 triggers secretion of IL-8, monocyte chemotactic protein-1, and TNF-α and induces neutrophil degranulation. Intracellularly, TREM-1 induces Ca2+ mobilization and tyrosine phosphorylation of extracellular signal-related kinase 1 (ERK1), ERK2 and phospholipase C-γ. To mediate activation, TREM-1 associates with the transmembrane adapter molecule DAP12. Thus, TREM-1 mediates activation of neutrophil and monocytes, and may have a predominant role in inflammatory responses.
8
Claudia Cantoni, Cristina Bottino, Massimo Vitale et al. · The Journal of Experimental Medicine · 1999 · 438 citations · Full text